Ruddy M C, Bialy G B, Kostis J B
UMDNJ-Robert Wood Johnson Medical School, Section of Hypertension, New Brunswick, New Jersey.
Angiology. 1989 Jan;40(1):45-50. doi: 10.1177/000331978904000109.
Enzymatically inactive renin (IR) is the predominant circulating form of renin. Sympathetic activity may influence plasma renin activity (PRA) by regulation of the conversion of IR to active renin (AR, PRA). It has been demonstrated previously that beta blockade lowers PRA at least partly through inhibition of this conversion process. The authors hypothesized that beta blockade and intrinsic sympathomimetic activity (ISA) would have opposing effects on production of AR from its inactive precursor. Eighteen primary hypertensives (12 male, 6 female, mean age 57.7 +/- 2.7) were entered in a placebo-controlled, double-blind crossover study of the effects of equipotent doses of pindolol and propranolol on mean +/- SEM systolic BP, diastolic BP, heart rate, active renin (AR), total renin (TR), inactive renin (IR), and % AR/TR. Drug dose was titrated to achieve a goal DBP of 90 mmHg or less. Active renin was defined as the rate of generation of angiotensin I in 37 degrees C plasma at pH 5.7. Total renin was determined by preincubation of plasma aliquots with 1.5 mg/mL trypsin in the presence of 5 mM benzamadine for one hour at -4 degrees C prior to assay of renin activity. Inactive renin was calculated as TR minus AR. The BP responses achieve by dose titration of propranolol and pindolol were virtually identical at rest, indicating equivalent depressor effects of the two beta blockers. Heart rate and active renin were, however, lowered to a much greater extent with propranolol as compared with pindolol. The lack of significant pindolol-induced fall in % AR/TR suggests that this drug has little net effect on the formation of AR from IR.(ABSTRACT TRUNCATED AT 250 WORDS)
无酶活性肾素(IR)是循环中肾素的主要形式。交感神经活动可能通过调节IR向活性肾素(AR,即血浆肾素活性,PRA)的转化来影响血浆肾素活性(PRA)。先前已证明β受体阻滞剂至少部分通过抑制这种转化过程来降低PRA。作者推测β受体阻滞剂和内在拟交感活性(ISA)对AR从其无活性前体的产生会有相反的影响。18名原发性高血压患者(12名男性,6名女性,平均年龄57.7±2.7岁)进入一项安慰剂对照、双盲交叉研究,该研究观察等效剂量的吲哚洛尔和普萘洛尔对平均收缩压±标准误、舒张压、心率、活性肾素(AR)、总肾素(TR)、无活性肾素(IR)以及AR/TR百分比的影响。滴定药物剂量以实现舒张压目标为90 mmHg或更低。活性肾素定义为在37℃、pH 5.7的血浆中血管紧张素I的生成速率。在测定肾素活性之前,将血浆等分试样与1.5 mg/mL胰蛋白酶在5 mM苯甲脒存在下于-4℃预孵育1小时来测定总肾素。无活性肾素通过TR减去AR来计算。在静息状态下,通过滴定普萘洛尔和吲哚洛尔剂量所达到的血压反应几乎相同,表明两种β受体阻滞剂的降压效果相当。然而,与吲哚洛尔相比,普萘洛尔使心率和活性肾素降低的程度要大得多。吲哚洛尔未引起AR/TR百分比显著下降,这表明该药物对IR形成AR的净影响很小。(摘要截断于250字)